Results

Total Results: 439 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

181. Behavioral Counseling to Promote a Healthy Diet and Physical Activity for CVD Prevention in Adults With Cardiovascular Risk Factors: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-97QgoUF_rpQSy-9yM9KCx
     November 24, 2020 - Treatment guidelines for hypertension and dyslipidemia have changed, generally recommending treatment … Clinical and cost outcomes of medical nutrition therapy for hypercholesterolemia: a controlled trial. … Motivational interviewing and problem solving treatment to reduce type 2 diabetes and cardiovascular … The Hypertension Optimal Treatment Study (the HOT Study). … One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk.

182. N3Veybr4Zdhzfqsw3Erlhe (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/N3VeYbr4ZdhZfqsw3ErLHE
     November 01, 2014 - Other factors, including treatment and control of diabetes and hyperlipidemia, are also reported to be … beyond current standard medical therapy. … Prevalence of hypertension in CREST and the SAPPHIRE trial was 85% to 88%, prevalence of diabetes in … and benefit beyond standard preventive treatments based on traditional cardio- vascular risk factors … of medical and surgical treatments, including the potential incremen- tal benefit of CEA.

183. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-myocardial-infarction-preventive-medication-1996
     January 01, 1996 - factors for coronary heart disease are smoking, high blood pressure, elevated serum cholesterol, obesity, diabetes … discuss aspirin prophylaxis with men who have risk factors for MI (e.g., high blood cholesterol, smoking, diabetes … risks of aspirin therapy before beginning treatment. … Foster JW, Hart RG Antithrombotic therapy for cerebrovascular disease: prevention and treatment of stroke … Fuster V, Dyken ML, Vokonas PS, et al Aspirin as a therapeutic agent in cardiovascular disease.

184. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(6).pdf
     November 01, 2014 - Potential harms also include side effects or complications of treatments. … Long-term harms of HIV antiretroviral therapy. Sexually transmitted infections 2. … Studies are needed that include psychotherapy and combined treatments and focus on MDD alone, as well … inhibitors and complementary or alternative treatments). … Studies on the effectiveness of antiretroviral therapy, adherence to treatment, and behavioral counseling

185. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
     November 01, 2014 - Potential harms also include side effects or complications of treatments. … Long-term harms of HIV antiretroviral therapy. Sexually transmitted infections 2. … Studies are needed that include psychotherapy and combined treatments and focus on MDD alone, as well … inhibitors and complementary or alternative treatments). … Studies on the effectiveness of antiretroviral therapy, adherence to treatment, and behavioral counseling

186. Recommendation: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-children-screening
     July 18, 2023 - Dyslipidemia due to homozygous FH or secondary causes (such as diabetes, nephrotic syndrome, or hypothyroidism … USPSTF reviewed 22 fair- to good-quality trials (n = 2257) examining the effectiveness of lipid-lowering treatments … good-quality trials (n = 1008) examining the effectiveness of various nonpharmacologic lipid-lowering treatments … A fair-quality observational study (n = 9393) evaluating the association of statins and new-onset diabetes … showed no difference in new diabetes diagnoses over up to 9 years of follow-up in individuals taking

187. Archived: Healthy Diet and Physical Activity: Counseling for CVD Prevention in Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-and-physical-activity-counseling-for-cvd-prevention-in-adults-2012
     June 15, 2012 - Recommendation Grade General adult population without a known diagnosis of hypertension, diabetes … Population General adult population without a known diagnosis of hypertension, diabetes … available to quantify a person's 10-year risk for cardiac events, such as the Framingham-based Adult Treatment … It does not apply to adults who have known CVD, hypertension, hyperlipidemia, or diabetes. … The Framingham-based Adult Treatment Panel III calculator (available at  https://hp2010.nhlbihin.net/

188. Archived: Final Research Plan: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan105/latent-tuberculosis-infection-screening-september-2016
     September 25, 2014 - ‡ Other treatments or combinations Comparisons KQs 1, 4: Screened vs. nonscreened … –5: No comparison; nonconcordant historical controls; comparisons with screening tests or treatments … will be defined based on an initial scan of the published literature, but may include persons with diabetes … 9 months, isoniazid twice weekly by directly observed therapy for 6 or 9 months, rifampin daily for … 4 months, or isoniazid plus rifapentine weekly by directly observed therapy for 3 months.

189. Archived: Final Research Plan: Depression in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan15/depression-in-children-and-adolescents-screening
     September 15, 2013 - attention deficit hyperactivity disorder, anxiety disorders) or chronic physical health conditions (e.g., diabetes … norepinephrine-dopamine reuptake inhibitors (NDRIs), or complementary and alternative medicine (CAM) treatments … sertraline, citalopram, and escitalopram Psychotherapy interventions: Cognitive-behavioral therapy … Paroxetine SNRIs, NDRIs, other types of off-label pharmacological interventions Other therapy … : CAM Electroconvulsive therapy Other interventions that are not primary

190. Archived: Final Research Plan: Aspirin to Prevent Cardiovascular Disease: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cardiovascular-diseas/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     October 07, 2013 - sex, smoking status, race/ethnicity, 10-year cardiovascular risk, or related risk conditions (e.g., diabetes … age, sex, smoking status, race/ethnicity, 10-year cardiovascular risk, related risk conditions (e.g., diabetes … available cardiovascular risk prediction tools commonly used in practice are good candidates to guide therapeutic … nonoral, nontablet forms of aspirin; exposure of less than 12 months Comparisons Placebo or no treatment

191. Archived: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
     March 15, 2009 - Thus, decisions about aspirin therapy should consider the overall risk for stroke and gastrointestinal … Treatment The optimum dose of aspirin for preventing cardiovascular disease events is not known. … among persons whose risk is sufficiently high for the benefits to outweigh the risks associated with treatment … prevention of stroke in women whose risk is sufficiently high for the benefits to outweigh the harms of treatment … from the American Heart Association and the American Diabetes Association.

192. Archived: Final Research Plan: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan142/obstructive-sleep-apnea-in-adults-screening-january-2017
     October 30, 2014 - Is there an association between OSA and incident diabetes? … assessments may occur in sleep laboratories or other settings) KQs 4, 5, 8: For nonsurgical treatments … of allergic rhinitis or similar treatments that might secondarily improve OSA by treating another condition … Studies focusing on potential worsening of OSA that might be caused by treatments for other … or inactive mandibular advancement devices; surgery vs. sham, conservative treatment, or no treatment

193. Behavioral Counseling Interventions to Promote a Healthful Diet and Physical Activity for CVD in Adults: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/2_e9yUNkzrtkkNKmn7YtCU
     September 01, 2012 - cardiovascular morbidity and mortality in adults without known CVD, hypertension, hyperlipidemia, or diabetes … Population: General adult population without a known diagnosis of hypertension, diabetes, hyperlipidemia … available to quantify a person’s 10-year risk for cardiac events, such as the Framingham-based Adult Treatment … It does not ap- ply to adults who have known CVD, hypertension, hyper- lipidemia, or diabetes. … The Framingham-based Adult Treatment Panel III calculator (available at http://hp2010.nhlbihin.net/atpiii

194. Archived: Final Research Plan: Carotid Artery Stenosis: Screening, December 2007 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan36/carotid-artery-stenosis-screening-december-2007
     January 23, 2014 - Treatment/ management interventions CEA, CAAS, medical therapy (e.g., aspirin, statins, antiplatelet … medical therapy (that includes treatment of traditional risk factors). … Risk stratification tools may include clinical factors (e.g., age, diabetes) and anatomic or imaging … treatment. … The USPSTF received several comments requesting that it consider the evidence on medical therapies for

195. Archived: Final Research Plan: Carotid Artery Stenosis: Screening, December 2007 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/ResearchPlanFinal/carotid-artery-stenosis-screening-december-2007
     January 23, 2014 - Treatment/ management interventions CEA, CAAS, medical therapy (e.g., aspirin, statins, antiplatelet … medical therapy (that includes treatment of traditional risk factors). … Risk stratification tools may include clinical factors (e.g., age, diabetes) and anatomic or imaging … treatment. … The USPSTF received several comments requesting that it consider the evidence on medical therapies for

196. Draft Research Plan: Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/unhealthy-alcohol-use-adolescents-adults-behavioral-counseling-interventions
     February 01, 2024 - how structural and social determinants of health affect risk for unhealthy alcohol use and access to treatment … not generalizable to primary care (e.g., psychiatric inpatients, persons who are court-mandated to treatment … Counseling interventions can vary in their approach (e.g., 12-step program, cognitive behavioral therapy … , or motivational enhancement therapy), specific strategies, delivery method (e.g., face-to-face, electronic … settings (e.g., diabetes management and dialysis clinics); research clinics; and office, home, or other

197. Recommendation: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening
     May 02, 2023 - 25 Some evidence from observational studies has explored the association between poorly controlled diabetes … However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes … tuberculosis exposure, HIV infection, risk factors increasing risk of progression to active disease (such as diabetes … Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis

198. Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KdQef_VDT2kmHDX4ddNWmR
     August 01, 2022 - .25 Some evidence from observational studies has explored the association between poorly controlled diabetes … However, there is insuffi- cient evidence on screening for and treatment of LTBI in persons with diabetes … tuberculosis exposure, HIV infec- tion, risk factors increasing risk of progression to active disease (such as diabetes … Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis

199. Recommendation: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/chronic-obstructive-pulmonary-disease-screening
     May 10, 2022 - to stop smoking. 12 Pharmacologic therapies (eg, bronchodilators and anti-inflammatory therapies) … (LABAs), long-acting muscarinic antagonists (LAMAs), inhaled corticosteroids (ICS), or combination therapy … cardiovascular risk association with LABAs or LAMAs was absent, or even reduced, with prevalent use of inhaled therapy … A second study found that ICS may increase the risk of developing diabetes (n = 9923 for diabetes onset … The USPSTF describes the benefits and harms of pharmacologic and nonpharmacologic COPD treatments in

200. Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/mggnaKHr496c8QCgHe9-tm
     May 01, 2021 - to stop smoking.12 Pharmacologic therapies (eg, bronchodilators and anti- inflammatory therapies) and … LABAs), long-acting muscarinic an- tagonists (LAMAs), inhaled corticosteroids (ICS), or combination therapy … cardiovascular risk association with LABAs or LAMAs was absent, or even reduced, with prevalent use of inhaled therapy … A second study found that ICS may increase the risk of de- veloping diabetes (n = 9923 for diabetes onset … The USPSTF describes the benefits and harms of pharmacologic and nonpharmacologic COPD treatments in